The economic burden of neuropathic pain in Canada

Journal of Medical Economics

Volumn 9, Issue 55-68, 2006, Pages 55-68

  Tarride, Jean Eric ^a,b   Collet, J P ^c   Choiniere M ^d   Rousseau, C ^a   Gordon, A ^e  

^a PFIZER INC   (United States)

^b MCMASTER UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d MONTREAL HEART INSTITUTE   (Canada)

^e MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANXIOLYTIC AGENT; CARBAMAZEPINE; CYCLOOXYGENASE 2 INHIBITOR; GABAPENTIN; HERBACEOUS AGENT; HYPNOTIC SEDATIVE AGENT; IBUPROFEN; MUSCLE RELAXANT AGENT; NAPROXEN; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN UPTAKE INHIBITOR; OPIATE; PARACETAMOL; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; CANADA; CERVICOBRACHIAL NEURALGIA; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DOSE RESPONSE; FEMALE; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEUROPATHIC PAIN; PAIN ASSESSMENT; PERIPHERAL NEUROPATHY; POSTHERPETIC NEURALGIA; PRESCRIPTION; PRIMARY MEDICAL CARE; PRODUCTIVITY; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW;

EID: 33745979527     PISSN: 1369698X     EISSN: None     Source Type: Journal    
DOI: 10.3111/200609055068     Document Type: Review

References (16)

1. Merskey H, Bogduk N, Editors. Classification of Chronic Pain: descriptions of chronic pain syndromes and definitions of pain terms, 2nd edn. Seattle, WA: IASP Press, 1994.
2. Meyer-Rosberg K, Kvanstrom A, Kinnman E et al. Peripheral neuropathic pain - a multidimensional burden for patients. European Journal of Pain 2001; 5: 379-389.
3. Mauskopf J, Austin R, Dix L et al. The Nottingham Health Profile as a measure of quality of life in zoster patients: convergent and discriminant validity. Quality of Life Research 1994; 3: 431-435.
4. Bowsher D. Neurogenic pain syndromes and their management. British Medical Bulletin 1991; 47: 644-666.
5. Schmader KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clinical Journal of Pain 2002; 18: 350-354.
6. Boulton AJ, Knight G, Drury J et al. The prevalence of symptomatic, diabetic neuropathy in an insulin-treated population. Diabetes Care 1985; 8: 125-128.
7. Ziegler D, Cries FA, Spuler M et al. The epidemiology of diabetic neuropathy. DiaCAN Multicenter Study Group. Diabetic Medicine 1993; 10 Suppl 2: 82S-S6S.
8. Maser RE, Steenkiste AR, Dorman JS et al Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 1989; 38: 1456-1461.
9. Opstelten W, Mauritz JW, de Wit NJ et al. Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Family Practice 2002; 19: 471-475.
10. Helgason S, Petursson G, Gudmundsson S et al. Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up. BMJ 2000; 321: 794-796.
11. Berger A, Dukes EM, Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders. Journal of Pain 2004; 5: 143-149.
12. Lachaine J, Tarride JE. Painful neuropathic disorders: an analysis of the Regie Assurance Maladie du Quebec (RAMQ) Database. Canadian Journal of Clinical Pharmacology 2005; 12: Poster #96.
13. Lachaine J, Tarride JE. Painful neuropathic disorders an Analysis of the Régie de L'Assurance Maladie du Québec (RAMQ) Database. Pain Research and Management 2005; 10: 92.
14. Zelman DC, Gore M, Dukes E et al. Validation of a modified version of the Brief Pain Inventory for painful diabetic peripheral neuropathy. Journal of Pain and Symptom Management 2005; 29: 401-410.
15. McDermott AM, Toelle TR, Rowbotham DJ et al. The burden of neuropathic pain: results from a cross-sectional survey. European Journal of Pain 2006; 10: 127-135.
16. Maetzel A, Li LC, Pencharz J et al; Community Hypertension and Arthritis Project Study Team. The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study. Annals of the Rheumatic Diseases 2004; 63: 395-401.